Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1161/01.res.10.1.105 | DOI Listing |
J Allergy Clin Immunol Glob
February 2023
University of California, San Diego, Calif.
Background: Hereditary angioedema (HAE) is a genetic condition characterized by dysregulation of the contact (kallikrein-bradykinin) pathway, leading to recurrent episodes of angioedema.
Objective: This project sought to determine whether a suspicion index screening tool using electronic health record (EHR) data can identify patients with an increased likelihood of a diagnosis of HAE.
Methods: A suspicion index screening tool for HAE was created and validated by using known patients with HAE from the medical literature as well as positive and negative controls from HAE-focused centers.
Ann Intern Med
June 2023
Department of Clinical Pharmacology and Clinical Research Platform Paris-East (URCEST-CRC-CRB), Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France (M.C., A.A.).
J Photochem Photobiol B
February 2023
Cancer Research Center, Jiangxi University of Chinese Medicine, Nanchang 330004, China; Jiangxi Engineering Research Center for Translational Cancer Technology, Nanchang 330004, China. Electronic address:
Cancer molecular imaging using specific probes designed to identify target proteins in cancer is a powerful tool to guide therapeutic selection, patient management, and follow-up. We demonstrated that icatibant may be used as a targeting probe for the significantly upregulated bradykinin B2R in colorectal cancer (CRC). Icatibant-based probes with high affinity towards bradykinin B2R were identified.
View Article and Find Full Text PDFActa Dermatovenerol Croat
April 2021
Anna Mrzljak MD, PhD, Department of Gastroenterology and Hepatology, University Hospital Center Zagreb, Kišpatićeva 12, Zagreb; School of Medicine, University of Zagreb, , Salata 3b, 10000 Zagreb, Croatia;
BMJ Case Rep
December 2020
Neurology, Cantonal Hospital of Baden, Baden, Aargau, Switzerland
A potential complication after intravenous administration of recombinant tissue plasminogen activators (rtPAs) for thrombolysis in acute ischaemic stroke is orolingual angioedema, with an incidence of 0.4%-7.9%.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!